- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.11. | Ferrer makes noise about shortcomings of pulmonary hypertension diagnostic, treatment pathways | ||
| 20.11. | On a roll, CDMO Samsung Bio strikes $668M production tie-up with European pharma | ||
| 20.11. | Gilead supports creation of 'sanctuary' resource hub for Black triple-negative breast cancer patients | ||
| 20.11. | Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll | ||
| 20.11. | Rapid growth spurt for UCB's Bimzelx continues with hidradenitis suppurativa nod marking 5th FDA approval | ||
| 20.11. | Plasma specialist Grifols shrugs off private equity firm Brookfield's potential €6.5B takeover offer | ||
| 20.11. | Roche files patent suit to fend off potential Evrysdi generics from Zydus, Natco | ||
| 20.11. | PCI and ChiRhoClin partner to prevent shortage of pancreatic diagnostic drug | ||
| 20.11. | FDA slams Indian drugmaker Unexo with warning letter for 'significant violations' | ||
| 20.11. | AstraZeneca to go on defense for Andexxa as FDA questions bleeding reversal agent's safety ahead of adcomm | ||
| 19.11. | With patent settlement, BeiGene defends blockbuster Brukinsa from MSN's generic threat until 2037 | ||
| 19.11. | Endo expands clonazepam recall to cover more than a dozen additional batches | ||
| 19.11. | Neurology patient groups call out pharma for inadequate investment in treating disease | ||
| 19.11. | England's NICE turns down cancer drug Enhertu-again-amid pricing stalemate with AstraZeneca, Daiichi Sankyo | ||
| 19.11. | Exact Sciences ramps up colon cancer outreach to Hispanic community with Carlos Ponce partnership | ||
| 19.11. | Ideaya hires Gilead leader to head up commercialization push | ||
| 19.11. | Taking its best shot at Roche, Merck scores in phase 3 trial of subcutaneous Keytruda | ||
| 19.11. | NeuroBo Pharmaceuticals rebrands to become MetaVia | ||
| 19.11. | Despite fears over RFK Jr. pick, industry should focus more on FDA job: analyst | ||
| 18.11. | Skills shortage still holding back pharma's digital transformation: survey | ||
| 18.11. | Sanofi lays out €40M to beef up transplant, diabetes drug production in France | ||
| 18.11. | Syndax scores FDA approval for Revuforj after it disappointed in another acute leukemia indication | ||
| 18.11. | VBI Vaccines recalls hepatitis B shot as it winds down operations | ||
| 18.11. | With new patient resource to close conversation gaps in rheumatic disease, AbbVie makes 'Rheum for Dialogue' | ||
| 18.11. | Eisai sunsets development, access program for withdrawn obesity med in Dravet syndrome |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
